drugset / Trial / NCT00452556

The ELDORADO (Eligard®, Docetaxel and Radiotherapy) Study

NCT00452556

Phase 2 Unknown 86 enrolled Nova Scotia Cancer Centre
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to see if sequence inversion of Intensity - modulated Radiotherapy (IMRT) for prostate cancer, can improve the safety and deliverability of concurrent docetaxel chemotherapy with long - term hormonal therapy. The hypothesis is that inverting the traditional sequence of radiotherapy can delay the time to treatment - induced bowel toxicity.

Timeline

Start
2007-05
Primary completion
2017-02
Completion
2017-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Docetaxel Small molecule 20 mg/m2
Background Leuprolide Other / unclassified

Indications